Oriola Corporation
Budget
€10 — €0
EP Access
0
accredited persons
Staff
1
0.1 FTE
EU Grants
None
Mission & Goals
Oriola is a health and wellbeing company operating in the Nordic countries. We help people to lead healthier lives by giving them access to sustainable health and wellbeing products and services. In Sweden, Oriola owns 50% of the country’s third-largest pharmacy chain, Kronans Apotek (Swedish Pharmacy Holding AB). In addition to pharmacies, our dose-dispensing, medical information and patient support services enhance the safety and effectiveness of pharmaceutical care. Our expert services support pharmaceutical companies throughout the entire lifecycle of medicines. Oriola’s supply chain ensures reliable and safe delivery of pharmaceuticals to pharmacies, hospital pharmacies, veterinarians and other healthcare operators. In 2024, Oriola Corporation’s net sales were 1.7 billion euros and we employed approx 800 professionals. Oriola Corporation is listed on Nasdaq Helsinki
EU Legislative Interests
EU's Pharmaceutical legislation Pharmaceutical Strategy Roadmap European Parliament Own-Initiative (INI) report on shortage of medicines. Green Deal CSRD
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
European Association of Pharmaceutical Full-line Wholesalers, (GIRP) The International Federation of Pharmaceutical Wholesalers (IFPW) LTH (Lääke- ja terveyshuolto ry) Läkemedelsdistributörernas Förening LDF Finnish Commerce Federation
Organisation Members
European Association of Pharmaceutical Full-line Wholesalers, (GIRP) Läkemedelsdistributörernas Förening LD
Commissioner Meetings
No recorded meetings with EU commissioners.